Skip to content
pharmanlifescience
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
Subscribe
Nordson

With an $800M Investment, Nordson will Acquire Atrion and its Medical Infusion Fluid Delivery Systems

Nordson officials announced that it has reached a deal to pay roughly $800 million to

Read More »
« Previous Page1 … Page3 Page4 Page5 Next »
pharmanlifescience
Pharmanlifescience transcends ordinary magazines, serving as a vibrant hub for collaboration and knowledge exchange within the dynamic life sciences arena …..Read More

© 2025 PHARMANLIFESCIENCE. All Rights Reserved

Quick Links

  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us

Latest Posts

Drug in Clinical Trials for Breast Cancer Shows Promise for Treating Blood Cancers

Drug in Clinical Trials for Breast Cancer Shows Promise for Treating Blood Cancers

Medicare’s $2,000 Cap on Out-of-Pocket Drug Costs Set to Offer Significant Savings AARP Reports

Medicare’s $2,000 Cap on Out-of-Pocket Drug Costs Set to Offer Significant Savings AARP Reports

UnitedHealth Surpasses Profit Expectations in Q4 Driven by Strong Health Services Performance

UnitedHealth Surpasses Profit Expectations in Q4 Driven by Strong Health Services Performance

Pfizer to Sell $3 Billion Stake in Haleon Reducing Ownership to 7.3%

Pfizer to Sell $3 Billion Stake in Haleon Reducing Ownership to 7.3%